Related Experiment Video

Updated: Apr 3, 2026

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
10:03

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids

Published on: August 2, 2024

1.9K

Targeting cell death: a promising approach for colorectal cancer therapy

Chengfeng Xiao1, Linda Oyang1,2, Xianjie Jiang2

  • 1Xiangya School of Medicine, Central South University, Hunan, 410013, Changsha, China.

Cancer Cell International
|April 2, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CRCDNA damageImmune therapyRCDTarget therapy

More Related Videos

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

7.0K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K

Related Experiment Videos

Last Updated: Apr 3, 2026

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
10:03

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids

Published on: August 2, 2024

1.9K
A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

7.0K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

Articles linked to this work by shared authors, journal, and citation graph.

Solvation-engineering-enabled quasi-solid positive electrode for four-electron aqueous Zn||Br batteries.

Nature communications·2026

Double-end blocker and split input mediated CRISPR-Cas12a system for modular single-base mutation detection with low abundance.

Biosensors & bioelectronics·2026

Development of a Novel Quantitative PCR Assay for Detecting Schistosoma japonicum in Field-Captured Rodents.

Pathogens (Basel, Switzerland)·2026

StripePoint-YOLO: Task-Adaptive Detection of Multi-Type Weld Seam Keypoints in Noisy Industrial Welding Scenes.

Sensors (Basel, Switzerland)·2026

Comparative effectiveness of aerobic training intensities in chronic stroke: a network meta-analysis of randomized controlled trials.

Frontiers in neurology·2026

Protein lactylation in cancer: principles, programmes and therapeutic opportunities.

Molecular cancer·2026

Cold atmospheric plasma affects metabolic processes in malignant melanoma.

Cancer cell international·2026

NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models.

Cancer cell international·2026

Quantifying target antigen-dependent CAR T-cell performance against AML.

Cancer cell international·2026

The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential.

Cancer cell international·2026

CAR-T and TIL therapies in solid tumors: barriers, clinical lessons, and convergent solutions.

Cancer cell international·2026

Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics.

Cancer cell international·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us